Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell. | APMIS | 2021 | 32996218 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| Loss of the laminin subunit alpha-3 induces cell invasion and macrophage infiltration in cutaneous squamous cell carcinoma. | Br J Dermatol | 2021 | 32767748 | PubTator, text mining | PubMed |
| Integrin α3β1 on Tumor Keratinocytes Is Essential to Maintain Tumor Growth and Promotes a Tumor-Supportive Keratinocyte Secretome. | J Invest Dermatol | 2021 | 32454065 | PubTator, text mining | PubMed |
| Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients. | Cancer Drug Resist | 2020 | 35582043 | PubTator, text mining | PubMed |
| De Novo designed 13 mer hairpin-peptide arrests insulin and inhibits its aggregation: role of OH-π interactions between water and hydrophobic amino acids. | RSC Adv | 2020 | 35497136 | PubTator, text mining | PubMed |
| MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers. | Transl Cancer Res | 2020 | 35117940 | PubTator, text mining | PubMed |
| Identification of hub genes correlated with the pathogenesis and prognosis in Pancreatic adenocarcinoma on bioinformatics methods. | Transl Cancer Res | 2020 | 35117820 | PubTator, text mining | PubMed |
| Predictions for high COL1A1 and COL10A1 expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses. | Transl Cancer Res | 2020 | 35117161 | PubTator, text mining | PubMed |
| The Crossroads of Periodontitis and Oral Squamous Cell Carcinoma: Immune Implications and Tumor Promoting Capacities. | Front Oral Health | 2020 | 35047982 | PubTator, text mining | PubMed |
| Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis. | Front Mol Biosci | 2020 | 33681288 | PubTator, text mining | PubMed |
| The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma. | Front Oncol | 2020 | 33680930 | PubTator, text mining | PubMed |
| Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches. | Front Cell Dev Biol | 2020 | 33644030 | PubTator, text mining | PubMed |
| Integrated Analysis Reveals ENDOU as a Biomarker in Head and Neck Squamous Cell Carcinoma Progression. | Front Oncol | 2020 | 33614471 | PubTator, text mining | PubMed |
| Construction of Bone Metastasis-Specific Regulation Network Based on Prognostic Stemness-Related Signatures in Breast Invasive Carcinoma. | Front Oncol | 2020 | 33585235 | PubTator, text mining | PubMed |
| Alterations in extracellular matrix composition during aging and photoaging of the skin. | Matrix Biol Plus | 2020 | 33543036 | PubTator, text mining | PubMed |
| Long Noncoding RNAs in the Metastasis of Oral Squamous Cell Carcinoma. | Front Oncol | 2020 | 33520725 | PubTator, text mining | PubMed |
| Amplifying Tumor-Stroma Communication: An Emerging Oncogenic Function of Mutant p53. | Front Oncol | 2020 | 33505920 | PubTator, text mining | PubMed |
| Integrative Analysis Reveals Common and Unique Roles of Tetraspanins in Fibrosis and Emphysema. | Front Genet | 2020 | 33424923 | PubTator, text mining | PubMed |
| LncRNA GIHCG Promotes the Development of Esophageal Cancer by Modulating miR-29b-3p/ANO1 Axis. | Onco Targets Ther | 2020 | 33408485 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=47